VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs Prologis, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisPrologis, Inc.
PLD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Prologis, Inc.'s moat claims, evidence, and risks.
View PLD analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 67 / 100 for Prologis, Inc.).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Prologis, Inc. has 2 segments (91.8% in Real Estate (Rental Operations and Development)).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Strong.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Prologis, Inc. has 7 across 4.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Prologis, Inc.
Real Estate (Rental Operations and Development)
Logistics/industrial real estate leasing & development
Global
Logistics users (retail, e-commerce, 3PL, manufacturing)
Owner/operator/developer (landlord)
91.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
AstraZeneca PLC strengths
Prologis, Inc. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Prologis, Inc. segments
Full profile >Real Estate (Rental Operations and Development)
Competitive
Strategic Capital (co-investment ventures / investment management)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.